Incidence of idiopathic pulmonary fibrosis in Korea based on the 2011 ATS/ERS/JRS/ALAT statement

International Journal of Tuberculosis and Lung Disease

Volumn 19, Issue 6, 2015, Pages 742-746

  Gjonbrataj, J ^a,b   Choi, W I ^a   Bahn, Y E ^c   Rho, B H ^c   Lee, J J ^d   Lee, C W ^e  

^a Keimyung University School of Medicine   (South Korea)

^b UNIVERSITY HOSPITAL CENTER MOTHER TERESA   (Albania)

^c Keimyung University   (South Korea)

^d Kyungpook National University   (South Korea)

^e Hankook General Hospital   (South Korea)

Author keywords

Epidemiology; Interstitial lung disease; IPF; Usual interstitial pneumonia

Indexed keywords

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FIBROSING ALVEOLITIS; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INCIDENCE; INTERSTITIAL LUNG DISEASE; KOREA; LUNG BIOPSY; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX RATIO; VERY ELDERLY; YOUNG ADULT; BIOPSY; BRONCHOALVEOLAR LAVAGE FLUID; COMPUTER ASSISTED TOMOGRAPHY; HEALTH SURVEY; IDIOPATHIC PULMONARY FIBROSIS; SOUTH KOREA; TIME;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; HEALTH SURVEYS; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; INCIDENCE; MALE; MIDDLE AGED; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84929391561     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.14.0650     Document Type: Article

References (30)

1. Demedts M, Wells A U, Anto J M, et al. Interstitial lung diseases: an epidemiological overview. Eur Respir J 2001; 32 (Suppl): 2s-16s.
2. Coultas D B, Zumwalt R E, BlackWC, et al. The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med 1994; 150: 967-972.
3. Thomeer M, Demedts M, Vandeurzen K, et al. Registration of interstitial lung diseases by 20 centres of respiratory medicine in Flanders. Acta Clin Belg 2001; 56: 163-172.
4. Navaratnam V, Fleming KM,West J, et al. The rising incidence of idiopathic pulmonary fibrosis in the UK. Thorax 2011; 66: 462-467.
5. von Plessen C, Grinde O, Gulsvik A. Incidence and prevalence of cryptogenic fibrosing alveolitis in a Norwegian community. Respir Med 2003; 97: 428-435.
6. Raghu G, Weycker D, Edelsberg J, et al. Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2006; 174: 810-816.
7. Fernandez Perez E R, Daniels C E, Schroeder D R, et al. Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study. Chest 2010; 137: 129-137.
8. Lai C C, Wang C Y, Lu H M, et al. Idiopathic pulmonary fibrosis in Taiwan: a population-based study. Respir Med 2012; 106: 1566-1574.
9. Noale M, Limongi F, Scafato E, et al. Longevity and health expectancy in an ageing society: implications for public health in Italy. Ann Ist Super Sanita 2012; 48: 292-299.
10. Liebow A. Definition and classification of interstitial pneumonias in human pathology. Prog Respir Res 1975; 8: 1.
11. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000; 161: 646-664.
12. American Thoracic Society, European Respiratory Society. American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002; 165: 277-304.
13. Noth I, Martinez F J. Recent advances in idiopathic pulmonary fibrosis. Chest 2007; 132: 637-650.
14. Carrington C B, Gaensler E A, Coutu R E, et al. Usual and desquamative interstitial pneumonia. Chest 1976; 69: 261-263.
15. Raghu G, CollardH R, Egan J J, et al. An official ATS/ERS/JRS/ ALATstatement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183: 788-824.
16. Travis W D, Costabel U, Hansell D M, et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013; 188: 733-748.
17. Kim D S. Introduction: health of the health care system in Korea. Soc Work Public Health 2010; 25: 127-141.
18. Kim D S. Special issue on the national health care system of South Korea. Soc Work Public Health 2010; 25: 125-126.
19. Jee SH, Sull JW, Park J, et al. Body-mass index and mortality in Korean men and women. N Engl J Med 2006; 355: 779-787.
20. Lee C H, Kim K, Hyun M K, et al. Use of inhaled corticosteroids and the risk of tuberculosis. Thorax 2013; 68: 1105-1113.
21. Hunninghake G W, Zimmerman M B, Schwartz D A, et al. Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2001; 164: 193-196.
22. Flaherty K R, King T E, Jr, Raghu G, et al. Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? Am J Respir Crit Care Med 2004; 170: 904-910.
23. Raghu G, Mageto Y N, Lockhart D, et al. The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease: a prospective study. Chest 1999; 116: 1168-1174.
24. Roelandt M, Demedts M, Callebaut W, et al. Epidemiology of interstitial lung disease (ILD) in Flanders: registration by pneumologists in 1992-1994. Working group on ILD, VRGT. Vereniging voor Respiratoire Gezondheidszorg en Tuberculosebestrijding. Acta Clin Belg 1995; 50: 260-268.
25. Costabel U. [Interstitial lung diseases]. Pneumologie 1996; 50 (Suppl 2): 611-614. [German]
26. Herman M, Kolek V. Diffuse interstitial lung disease-evaluation with high-resolution computed tomography. Acta Univ Palacki Olomuc Fac Med 1993; 135: 25-30.
27. Karakatsani A, Papakosta D, Rapti A, et al. Epidemiology of interstitial lung diseases in Greece. Respir Med 2009; 103: 1122-1129.
28. Hodgson U, Laitinen T, Tukiainen P. Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland. Thorax 2002; 57: 338-342.
29. Gribbin J, Hubbard R B, Le Jeune I, et al. Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax 2006; 61: 980-985.
30. Hutchinson J P, McKeever T M, Fogarty AW, et al. Increasing global mortality from idiopathic pulmonary fibrosis in the twenty-first century. Ann Am Thorac Soc 2014; 11: 1176-1185.